Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-01

Clinical Trial Update: The Blood Saving Effect of Tranexamic Acid in Total Knee Arthroplasty With Rivaroxaban as Thromboprophylaxis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the blood-sparing effect of tranexamic acid in total knee arthroplasty performed with rivaroxaban thromboprophylaxis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivaroxaban (rivaroxaban)
  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Osteoarthritis, Knee | Phase 4 | Status: COMPLETED